LABU vs. MVLL

Last updated Jun 3, 2026

LABU (Direxion Daily S&P Biotech Bull 3x Shares) and MVLL (GraniteShares 2x Long MRVL Daily ETF) are both Leveraged Equities funds - LABU tracks the S&P Biotechnology Select Industry Index (300%) while MVLL tracks the Marvell Technology Inc. (MRVL). Both are passively managed. Over the past year, LABU returned 193.25% vs 1163.51% for MVLL. At a 0.31 correlation, their price movements are largely independent. LABU charges 1.12%/yr vs 1.50%/yr for MVLL.

Performance

LABU vs. MVLL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily S&P Biotech Bull 3x Shares (LABU) and GraniteShares 2x Long MRVL Daily ETF (MVLL). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, LABU achieves a -0.77% return, which is significantly lower than MVLL's 779.83% return.

LABU

• 1D: -12.94%
• 1M: -8.90%
• YTD: -0.77%
• 6M: 7.41%
• 1Y: 193.25%
• 3Y*: 6.21%
• 5Y*: -33.29%
• 10Y*: -13.92%

MVLL

• 1D: 65.00%
• 1M: 176.74%
• YTD: 779.83%
• 6M: 610.16%
• 1Y: 1,163.51%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

LABU vs. MVLL - Yearly Performance Comparison

	2026 (YTD)	2025
LABU Direxion Daily S&P Biotech Bull 3x Shares	-0.77%	107.39%
MVLL GraniteShares 2x Long MRVL Daily ETF	779.83%	-10.19%

Correlation

The correlation between LABU and MVLL is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.27
Correlation (All Time) Calculated using the full available price history since Mar 10, 2025	0.31

LABU vs. MVLL - Sectors Allocation Comparison

Sectors	LABU	MVLL
Healthcare	99.8%	-
Financial Services	0.2%	-
Basic Materials	0.0%	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Industrials	-	-
Real Estate	-	-
Technology	-	66.6%
Utilities	-	-

Return for Risk

LABU vs. MVLL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LABU

LABU Risk / Return Rank: 76
LABU Sharpe Ratio Rank: 78
LABU Sortino Ratio Rank: 62
LABU Omega Ratio Rank: 55
LABU Calmar Ratio Rank: 94
LABU Martin Ratio Rank: 90

MVLL

MVLL Risk / Return Rank: 96
MVLL Sharpe Ratio Rank: 99
MVLL Sortino Ratio Rank: 93
MVLL Omega Ratio Rank: 92
MVLL Calmar Ratio Rank: 99
MVLL Martin Ratio Rank: 97

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LABU vs. MVLL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bull 3x Shares (LABU) and GraniteShares 2x Long MRVL Daily ETF (MVLL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	LABU	MVLL	Difference
Sharpe ratio Return per unit of total volatility	2.57	8.85	-6.28
Sortino ratio Return per unit of downside risk	2.91	4.74	-1.82
Omega ratio Gain probability vs. loss probability	1.34	1.62	-0.28
Calmar ratio Return relative to maximum drawdown	7.09	24.93	-17.84
Martin ratio Return relative to average drawdown	20.95	51.99	-31.05
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

LABU vs. MVLL - Sharpe Ratio Comparison

The current LABU Sharpe Ratio is 2.57, which is lower than the MVLL Sharpe Ratio of 8.85. The chart below compares the historical Sharpe Ratios of LABU and MVLL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	LABU	MVLL	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.57	8.85	-6.28
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.35	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.15	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.24	3.13	-3.37

Drawdowns

LABU vs. MVLL - Drawdown Comparison

The maximum LABU drawdown since its inception was -99.18%, which is greater than MVLL's maximum drawdown of -59.02%. Use the drawdown chart below to compare losses from any high point for LABU and MVLL.

Drawdown Indicators

	LABU	MVLL	Difference
Max Drawdown Largest peak-to-trough decline	-99.18%	-59.02%	-40.16%
Max Drawdown (1Y) Largest decline over 1 year	-30.70%	-48.93%	+18.23%
Max Drawdown (3Y) Largest decline over 3 years	-78.30%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-97.59%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-98.96%	—	—
Current Drawdown Current decline from peak	-96.50%	0.00%	-96.50%
Average Drawdown Average peak-to-trough decline	-81.67%	-22.49%	-59.18%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.40%	23.46%	-13.06%

Volatility

LABU vs. MVLL - Volatility Comparison

The current volatility for Direxion Daily S&P Biotech Bull 3x Shares (LABU) is 28.40%, while GraniteShares 2x Long MRVL Daily ETF (MVLL) has a volatility of 61.15%. This indicates that LABU experiences smaller price fluctuations and is considered to be less risky than MVLL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LABU	MVLL	Difference
Volatility (1M) Calculated over the trailing 1-month period	28.40%	61.15%	-32.75%
Volatility (6M) Calculated over the trailing 6-month period	60.11%	95.96%	-35.85%
Volatility (1Y) Calculated over the trailing 1-year period	76.20%	133.02%	-56.82%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	95.56%	139.75%	-44.19%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	95.43%	139.75%	-44.32%

LABU vs. MVLL - Expense Ratio Comparison

LABU has a 1.12% expense ratio, which is lower than MVLL's 1.50% expense ratio.

Dividends

LABU vs. MVLL - Dividend Comparison

LABU's dividend yield for the trailing twelve months is around 0.78%, while MVLL has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
LABU Direxion Daily S&P Biotech Bull 3x Shares	0.78%	0.84%	0.35%	0.35%	0.00%	0.00%	0.00%	0.28%	0.64%	0.17%
MVLL GraniteShares 2x Long MRVL Daily ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both LABU and MVLL in my portfolio?

LABU and MVLL have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, LABU or MVLL?

MVLL has higher volatility (61.15%) compared to LABU (28.40%). In terms of maximum drawdown, LABU dropped -99.18% vs MVLL's -59.02%.

Which ETF is better, LABU or MVLL?

On 1-year performance, MVLL leads with 1163.51% vs 193.25% for LABU. On fees, LABU is cheaper at 1.12% per year. On volatility, LABU has been the lower-risk option at 28.40%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, LABU or MVLL?

Over the 1-year period, MVLL has performed better with a 1163.51% return vs 193.25%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, LABU or MVLL?

LABU is cheaper with a 1.12% expense ratio, compared with 1.50% for MVLL.

Which ETF pays a higher dividend yield, LABU or MVLL?

LABU has the higher dividend yield at 0.78%, compared with 0.00% for MVLL.

What is the main difference between LABU and MVLL?

LABU tracks S&P Biotechnology Select Industry Index (300%), while MVLL tracks Marvell Technology Inc. (MRVL). They also come from different issuers: Direxion and GraniteShares. Their fees differ too: 1.12% for LABU and 1.50% for MVLL.

Which has better risk-adjusted returns?

MVLL currently has the higher Sharpe Ratio (8.85 vs 2.57), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.